Clinton Foundation partner raking in millions from EpiPen price-gouging
by: David Gutierrez
NaturalNews.com
Tuesday, August 30, 2016
In 2007, pharmaceutical company Mylan purchased the rights to the brand name device EpiPen, which is used to inject epinephrine in the case of a life-threatening anaphylactic allergic reaction. At that time, the devices cost $57 each. The price has since risen steadily to $609.
Roughly 43 million people in the United States are at risk of anaphylactic reactions, and the high price of EpiPens is placing life-saving medication beyond their reach.
On August 24, presidential candidate Hillary Clinton called Mylan’s pricing “outrageous,” saying, “It’s just the latest troubling example of a company taking advantage of its consumers.”
What Clinton did not mention is that Mylan has a history of donating to the Clinton Foundation.
Mylan lobbying yields results
The Rest…HERE
